Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2) (N-Term) Peptide
CITED2
Reactivité: Humain
BP
Sodium azide
-
- Antigène Tous les produits CITED2
- CITED2 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2))
- Protein Region
- N-Term
- Origine
- Humain
- Application
- Blocking Peptide (BP)
- Attributs du produit
-
18 amino acids near the amino terminus of human CITED2.
Human
-
-
- Indications d'application
- CITED2 peptide is used for blocking the activity of CITED2.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Date de péremption
- 12 months
-
- Antigène
- CITED2 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2))
- Synonymes
- mrg1 Peptide, p35srj Peptide, zgc:103418 Peptide, CITED2 Peptide, cite2 Peptide, ASD8 Peptide, MRG-1 Peptide, MRG1 Peptide, P35SRJ Peptide, VSD2 Peptide, AI835299 Peptide, ER154-like Peptide, Mrg1 Peptide, Msg2 Peptide, Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2 Peptide, Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 Peptide, Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 Peptide, Cbp/p300-interacting transactivator 2 Peptide, Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2 L homeolog Peptide, cited2 Peptide, CITED2 Peptide, cite2 Peptide, Cited2 Peptide, cited2.L Peptide
-
Vous êtes ici:
